Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Tse, Hung-Fat  [Clear All Filters]
2024
Ho I, Wong C-K, Wong Y-K, Lam T-H, Leung ISze-Him, Lin M, Lui DTak-Wai, Kwok WChun, Tam C-C, Chan Y-H, et al. Aromatase Inhibitor Therapy Increases the Risk of New-Onset Atrial Fibrillation in Patients With Breast Cancer. JACC Asia. 2024;4(2):150-160.
2023
Li J, Song F, Chen R, Yang J, Liu J, Huang L, Duan F, Kou M, Lian BXuan, Zhou X, et al. Bradykinin-pretreated Human cardiac-specific c-kit Cells Enhance Exosomal miR-3059-5p and Promote Angiogenesis Against Hindlimb Ischemia in mice. Stem Cell Rev Rep. 2023.
Tse Y-H, Tuet C-Y, Lau K-K, Tse H-F. Dietary modification for prevention and control of high blood pressure. Postgrad Med J. 2023.
Ngan H-T, Tse H-F. Expanding Indications for Pulse Field Ablation Beyond Treatment of Cardiac Arrhythmias?. Heart Rhythm. 2023.
Lau C-P, Tse H-F. Primary Prevention of Sudden Cardiac Death in Asia. JACC Asia. 2023;3(3):346-348.
Lauf C-P, Tse H-F. Targeting Cardiac Conduction System as Pacing for Heart Failure. JACC Clin Electrophysiol. 2023.
Ma C-Y, Zhai Y, Li CTony, Liu J, Xu X, Chen H, Tse H-F, Lian Q. Translating mesenchymal stem cell and their exosome research into GMP compliant advanced therapy products: Promises, problems and prospects. Med Res Rev. 2023.
2022
Fu J, Jiang L, Yu B, Liu Y, Wei R, Hu Y, Ho W-I, Yang B, Chu M, Tse H-F, et al. Generation of a human iPSC line CIBi010-A with a reporter for ASGR1 using CRISPR/Cas9. Stem Cell Res. 2022;62:102800.
Ho W-I, Hu Y, Cheng C-W, Wei R, Yang J, Li N, Au K-W, Tse Y-L, Wang Q, Ng K-M, et al. Liposome-encapsulated curcumin attenuates HMGB1-mediated hepatic inflammation and fibrosis in a murine model of Wilson's disease. Biomed Pharmacother. 2022;152:113197.
2021
Ma CYan, Li C, Zhou X, Zhang Z, Jiang H, Liu H, Chen HJoyce, Tse H-F, Liao C, Lian Q. Management of adrenoleukodystrophy: From pre-clinical studies to the development of new therapies. Biomed Pharmacother. 2021;143:112214.
Sun S-J, Wei R, Li F, Liao S-Y, Tse H-F. Mesenchymal stromal cell-derived exosomes in cardiac regeneration and repair. Stem Cell Reports. 2021.
2020
Zhang Y, Zhang Z, Chen P, Ma CYan, Li C, Au TYK, Tam V, Peng Y, Wu R, Cheung KMan Chee, et al. Directed Differentiation of Notochord-like and Nucleus Pulposus-like Cells Using Human Pluripotent Stem Cells. Cell Rep. 2020;30(8):2791-2806.e5.
Zhou M, Wei R, Jiang Y, Fu J, Liu Y, Yang B, Yu B, Lin Y, Ran X, Lai W-H, et al. Generation of a human iPSC line GIBHi002-A-2 with a dual-reporter for NKX2-5 using TALENs. Stem Cell Res. 2020;50:102120.
Li J, Li Y, Zhan X-Y, Ran X, Tse H-F, Dang S, Nie Y, Huang K. Generation of GADD45A gene knockout human embryonic stem cell line using CRISPR/Cas9. Stem Cell Res. 2020;49:102090.
2019
Mura M, Lee Y-K, Pisano F, Ginevrino M, Boni M, Calabrò F, Crotti L, Valente EMaria, Schwartz PJ, Tse H-F, et al. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation. Stem Cell Res. 2019;37:101437.
Mura M, Lee Y-K, Pisano F, Ginevrino M, Boni M, Calabrò F, Crotti L, Valente EMaria, Schwartz PJ, Tse H-F, et al. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation. Stem Cell Res. 2019;37:101431.
2018
Ng K-M, Lau Y-M, Dhandhania V, Cai Z-J, Lee Y-K, Lai W-H, Tse H-F, Siu C-W. Empagliflozin Ammeliorates High Glucose Induced-Cardiac Dysfuntion in Human iPSC-Derived Cardiomyocytes. Sci Rep. 2018;8(1):14872.
Zhuang Q, Li W, Benda C, Huang Z, Ahmed T, Liu P, Guo X, Ibañez DP, Luo Z, Zhang M, et al. Publisher Correction: NCoR/SMRT co-repressors cooperate with c-MYC to create an epigenetic barrier to somatic cell reprogramming. Nat Cell Biol. 2018.
2016
Lian Q, Zhang Y, Liang X, Gao F, Tse H-F. Directed Differentiation of Human-Induced Pluripotent Stem Cells to Mesenchymal Stem Cells. Methods Mol Biol. 2016;1416:289-298.
Y Y Cheung C, Tang CS, Xu A, Lee C-H, Au K-W, Xu L, H Y Fong C, Kwok KHM, Chow W-S, Woo Y-C, et al. Exome-chip association analysis reveals an Asian-specific missense variant in PAX4 associated with type 2 diabetes in Chinese individuals. Diabetologia. 2016.
2015
Lee Y-K, Lau Y-M, Ng K-M, Lai W-H, Ho S-L, Tse H-F, Siu C-W, Ho PWing-Lok. Efficient attenuation of Friedreich's ataxia (FRDA) cardiomyopathy by modulation of iron homeostasis-human induced pluripotent stem cell (hiPSC) as a drug screening platform for FRDA. Int J Cardiol. 2015;203:964-971.
Zhang Y, Liang X, Liao S, Wang W, Wang J, Li X, Ding Y, Liang Y, Gao F, Yang M, et al. Potent Paracrine Effects of human induced Pluripotent Stem Cell-derived Mesenchymal Stem Cells Attenuate Doxorubicin-induced Cardiomyopathy. Sci Rep. 2015;5:11235.
2014
Zhang J, Ho JChung-Yee, Chan Y-C, Lian Q, Siu C-W, Tse H-F. Overexpression of myocardin induces partial transdifferentiation of human-induced pluripotent stem cell-derived mesenchymal stem cells into cardiomyocytes. Physiol Rep. 2014;2(2):e00237.
Lo C-Y, Tjong Y-W, Ho JChung-Yee, Siu C-W, Cheung S-Y, Tang NL, Yu S, Tse H-F, Yao X. An upregulation in the expression of vanilloid transient potential channels 2 enhances hypotonicity-induced cytosolic ca(2+) rise in human induced pluripotent stem cell model of hutchinson gillford progeria. PLoS One. 2014;9(1):e87273.
2013
Zhang Y-Y, Yue J, Che H, Sun H-Y, Tse H-F, Li G-R. BKCa and hEag1 channels regulate cell proliferation and differentiation in human bone marrow-derived mesenchymal stem cells. J Cell Physiol. 2013.